Malignant bone tumors: limb sparing versus amputation.

  title={Malignant bone tumors: limb sparing versus amputation.},
  author={Matthew R Dicaprio and Gary E. Friedlaender},
  journal={The Journal of the American Academy of Orthopaedic Surgeons},
  volume={11 1},
Amputation, once the mainstay of treatment of malignant bone tumors, now is used selectively and infrequently. Most patients are candidates for limb-sparing procedures because of effective chemotherapeutic agents and regimens, improved imaging modalities, and advances in reconstructive surgery. Patient age as well as tumor location and extent of disease help define the most appropriate surgical alternatives. Options for skeletal reconstruction include modular endoprostheses, osteoarticular or… CONTINUE READING